Choi Y, Jiang F, An H, Park HJ, Choi JH, Lee H. A pharmacogenomic study on the pharmacokinetics of tacrolimus in healthy subjects using the DMETTM Plus platform. The Pharmacogenomics Journal. 2017;17(2):174-179

Lee HA, Lee S, Yim SV, Kim BH. Bioequivalence of two formulations of pregabalin 150-mg capsules under fasting conditions in healthy male subjects. International Journal of Clinical Pharmacology and Therapeutics. 2017 Feb, 55(2):171-176. doi: 10.5414/CP202698

Ju SM, Kim MS, Jo YS, Jeon YM, Bae JS, Pae HO, Jeon BH. Licorice and its active compound glycyrrhizic acid ameliorates cisplatin-induced nephrotoxicity through inactivation of p53 by scavenging ROS and overexpression of p21 in human renal proximal tubular epithelial cells. Eur Rev Med Pharmacol Sci. 2017 Feb. 21(4):890-899.

Lee H, Yim SV, Kim BH, Lee S. Comparative pharmacokinetic and bioequivalence evaluation of two formulations of morniflumate 350-mg tablets in healthy male subjects. Int J Clin Pharmacol Ther. 2017 Jan;55 (2017)(1):95-101.

Suh HY, Peck C, Yu K-S, Lee H. Determination of the starting dose in the first-in-human clinical trials with monoclonal antibodies: a systematic review of papers published between 1990 and 2013. Drug Des Devel Ther. 2016;Volume 10:4005-4016.

Kim A, Lim KS, Lee H, Chung H, Yoon SH, Yu KS, Cho JY, Jang IJ, Chung JY. A thorough QT study to evaluate the QTc prolongation potential of two neuropsychiatric drugs, quetiapine and escitalopram, in healthy volunteers. Int Clin Psychopharmacol. 2016;31(4):210-217.

Yoon S, Shin D, Lee H, Jang IJ, Yu KS. Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjects. Drug design, development and therapy. 2015;9:5033-5049.

Chung H, Lee H, Han H, et al. A pharmacokinetic comparison of two voriconazole formulations and the effect of CYP2C19 polymorphism on their pharmacokinetic profiles. Drug design, development and therapy. 2015;9:2609-2616.

Oh J, Ji S, Lee H, Yu KS, Jang IJ. Response to \"Induction of both P-glycoprotein and specific cytochrome P450 by Aspirin eventually does not alter the antithrombotic effect of clopidogrel\". Clin. Pharmacol. Ther. 2015;97(4):325

Park SI, Lee H, Oh J, Lim KS, Jang IJ, Kim JA, Jung JH, Yu KS. A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects. Drug design, development and therapy. 2015;9:729-736.

Lee H. Erratum to: Is Extrapolation of the Safety and Efficacy Data in One Indication to Another Appropriate for Biosimilars? AAPS J. 2015;17(6):1520-1521

Chung I, Yoon S, Yi S, Kim B-H, Yim S-V, Jang I-J, Lee H. A bioequivalence study of two levofloxacin tablets in healthy male subjects. Translational and Clinical Pharmacology. 2014;22(2):102.